🔗 Share this article

Chancellor Rachel Reeves has announced she is planning "focused measures to tackle cost of living challenges" in next month's Budget.

Speaking to media outlets, she stated that curbing price rises is a shared responsibility of both the government and the Bank of England.

The United Kingdom's price growth is forecast to be the highest among the Group of Seven developed nations this calendar year and next.

Potential Utility Cost Interventions

Sources suggest the administration could take action to lower utility costs, for instance by slashing the current 5% level of value-added tax applied on energy.

An additional possibility is to cut some of the policy costs presently included in household expenses.

Budgetary Constraints and Expert Predictions

The administration will receive the latest report from the official forecaster, the Office for Budget Responsibility, on Monday, which will reveal how much scope there is for such measures.

The consensus from the majority of economists is that Reeves will have to introduce higher taxes or expenditure reductions in order to fulfill her voluntary debt limits.

Earlier on Thursday, calculations suggested there was a £22 billion deficit for the Treasury chief to address, which is at the lower end of forecasts.

"It is a shared task between the Bank of England and the administration to continue tackling some of the sources of inflation," Reeves stated to the BBC in Washington, at the annual meetings of the International Monetary Fund and World Bank.

Tax Commitments and Global Issues

While much of the focus has been on expected tax rises, the Treasury chief said the latest information from the OBR had not changed her vow to campaign commitments not to increase tax levels on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and trade concerns for the fiscal revenue measures, likely to be directed on those "wealthiest."

International Trade Disputes

Addressing apprehensions about the United Kingdom's commercial links with the Asian nation she said: "The UK's security interests invariably take priority."

Recent declaration by Chinese authorities to tighten export controls on rare earths and other materials that are essential for advanced tech manufacturing led US President the US President to threaten an extra 100% tariff on goods from China, increasing the risk of an full-scale trade war between the two global powers.

The American finance chief labeled the Chinese decision "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the US offer to join its battle with China, Reeves said she was "deeply worried" by China's actions and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "harmful for the world economy and causes further obstacles."

"It is my opinion there are areas where we must address China, but there are also valuable opportunities to sell into China's economy, including banking sector and other areas of the economy. We've got to get that equilibrium correct."

The chancellor also confirmed she was working with other major economies "on our own essential resources approach, so that we are less reliant."

Health Service Medicine Pricing and Funding

The Chancellor also admitted that the price the NHS pays for medicines could rise as a consequence of ongoing talks with the Trump administration and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or scrapping projects in the UK, with several blaming the modest returns they are receiving.

Last month, the Science Minister said the price the NHS spends on medicines would need to rise to stop companies and drug research funding departing from the United Kingdom.

The Chancellor informed the BBC: "It has been observed due to the payment system, that medical research, recent pharmaceuticals have not been provided in the UK in the way that they are in other EU nations."

"The objective is to guarantee that patients getting treatment from the NHS are able to access the best essential drugs in the world. And so we are looking at these issues, and... aiming to obtain more funding into the UK."